According to health officials and local media reports, suspected and confirmed cases of monkeypox are being investigated in the United States, Canada, Spain, Portugal, and the United Kingdom.
- One case was recently confirmed in the United States, while 13 suspected cases are currently being investigated in Canada.
- According to health officials, five illnesses have been verified in Portugal and seven in Spain.
- Monkeypox is particularly widespread in Central and West Africa’s rural areas.
- Travel to the area is frequently connected to cases of the disease outside of the region.
According to the National Health Service of the United Kingdom, monkeypox is a rare viral infection that is usually mild and lasts only a few weeks.
Table of Contents
What exactly is monkeypox?
On May 7, the first case of the disease was reported in the United Kingdom. According to the UK Health Security Agency, the patient had just travelled to Nigeria, where they are believed to have contracted the illness before arriving in England.
- In the UK, there are already nine confirmed cases. Although the source of these infections has not been determined, the World Health Organization (WHO) reports that instances appear to have been “locally acquired.”
- After European health organisations were notified of the findings in the UK, confirmed cases were recorded in Portugal and Spain.
- Most recently, health officials in the US state of Massachusetts reported that a man had contracted monkeypox.
- He had recently returned from Canada, where 13 suspected instances of the virus are being probed, according to local media.
According to health officials, the individual has been hospitalised and is in “great condition” and “poses no risk to the public.”
Monkey pox has symptoms that are comparable to smallpox but are less severe. Infected individuals get flu-like symptoms such as fever, body pains, and chills, as well as swollen lymph nodes. A characteristic rash emerges one to three days after the onset of fever, usually on the face.
Monkey pox virus infection currently has no documented, safe treatment. A monkeypox vaccine, antivirals, and vaccinia immune globulin (VIG) can all be utilised to control a monkeypox outbreak in the United States.
Monkeypox death rate
The case-fatality rate for monkeypox in Africa is estimated to be between 1% and 15%, with small children having the highest risk of death. In one study of 300 patients in the Democratic Republic of Congo, the total mortality rate was 10%, with unvaccinated children dying at a rate of 15-20%.
The Jynneos vaccine was authorised by the US FDA in 2019 to protect humans from monkeypox. In 2013, the European Medicines Agency authorised Jynneos (Imvamune or Imvanex) for the prevention of smallpox and monkeypox sickness in adults.
In the United Kingdom, intensive public health measures should be maintained. Case searching and local rash-illness surveillance should be improved in the GBMSM and larger community, as well as in basic and secondary health care settings, in addition to continued forward and backward contact tracing and source tracing. During the hypothesised and known infectious phases, that is, during the prodromal and rash stages of the illness, any patient with suspected monkeypox should be evaluated and isolated with supportive care.
For preventing potential secondary cases and effective management of the current outbreak, timely contact tracing, surveillance measures, and raising awareness among health care providers, including sexual health and dermatology clinics, are critical. Pharmaceutical countermeasures can also be used in conjunction with exploratory regimens.
Read also: Halo Flight: A charity air ambulance service
Standard, contact, and droplet infection control precautions should be used by health workers and other caregivers caring for patients with suspected or confirmed monkey pox. Samples taken from people suspected of having monkey pox or animals suspected of having monkey pox virus infection should be handled securely by skilled personnel in well-equipped laboratories.
Any sickness contracted while travelling or after returning from an endemic location should be reported to a healthcare provider, together with details of all recent travel and immunisation history. Residents and visitors to endemic nations should avoid contact with diseased animals (dead or alive) that may carry the monkeypox virus (rodents, marsupials, and primates), as well as eating or handling wild wildlife (bush meat). Hand hygiene should be emphasised by using soap and water or an alcohol-based sanitizer.
International travel or trade: Based on current information, WHO does not propose any restrictions on travel to or trade with the United Kingdom.
The WHO continues to keep a careful eye on the situation, which is rapidly changing.
The monke ypox virus, which belongs to the orthopoxvirus family, causes it. Monkeypox is spread by inhaling big droplets and coming into contact with infected skin sores or contaminated items.
Monkeypox virus infection currently has no documented, safe treatment. A monkeypox vaccine, antivirals, and vaccinia immune globulin (VIG) can all be utilised to control a monkeypox outbreak in the United States. Learn more about the smallpox vaccine, antivirals, and treatments for the virus.
Monkeypox symptoms in people are similar to, but less severe than, smallpox symptoms. Fever, headaches, muscle aches, and tiredness are among the symptoms of monkeypox. The fundamental distinction between smallpox and monkeypox symptoms is that monkeypox causes lymph node swelling (lymphadenopathy), but smallpox does not.
Monkeypox has symptoms that are comparable to smallpox but are less severe. Infected individuals get flu-like symptoms such as fever, body pains, and chills, as well as swollen lymph nodes. A characteristic rash emerges one to three days after the onset of fever, usually on the face.